Jaypirca

Pirtobrutinib · Bruton's Tyrosine Kinase (BTK) Inhibitor

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma, Waldenström's Macroglobulinemia.

Contraindications

Hypersensitivity to active ingredient or any formulation excipients.

Side Effects & Warnings

Bleeding/hemorrhage, cardiac arrhythmias (atrial fibrillation), hypertension, cytopenias, infections, diarrhea.

Drug & Dietary Interactions

Caution with strong CYP3A inhibitors or inducers; review concurrent medications.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.